1. Safety, Pharmacokinetics and Pharmacodynamics of Gs-9620, An Oral Toll-Like Receptor 7 Agonist. Issue 3 (April 2013) Authors: Lopatin, Uri; Wolfgang, Grushenka; Tumas, Daniel; Frey, Christian R; Ohmstede, Carol; Hesselgesser, Joseph; Kearney, Brian; Moorehead, Lisa; Subramanian, G Mani; McHutchison, John G Journal: Antiviral therapy Issue: Volume 18:Issue 3(2013) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial. (February 2020) Authors: Yuen, Man-Fung; Agarwal, Kosh; Gane, Edward J; Schwabe, Christian; Ahn, Sang Hoon; Kim, Dong Joon; Lim, Young-Suk; Cheng, Wendy; Sievert, William; Visvanathan, Kumar; Ruby, Eric; Liaw, Sandy; Yan, Ran; Huang, Qi; Colonno, Richard; Lopatin, Uri Journal: Lancet gastroenterology and hepatology Issue: Volume 5:Number 2(2020) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗